Back to search

Article

Inducing TRIB2 Targeted Protein Degradation to Reverse Chemoresistance in Acute Myeloid Leukaemia

2025-10-05

Abstract excerpt

The myeloid oncogene TRIB2 is a key driver of acute myeloid leukaemia (AML) pathogenesis, promoting chemoresistance and blocking differentiation through ubiquitin-mediated degradation of the C/EBPα transcription factor. Despite its stable and sometimes elevated expression across AML subtypes, TRIB2 remains a clinically-untargeted vulnerability. Here, we present a comprehensive investigation into TRIB2 degradation...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
77f50927-45c7-5c80-8526-ba913a95f0e4
DOI
10.1101/2025.10.03.680259
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Inducing TRIB2 Targeted Protein Degradation to Reverse Chemoresistance in Acute Myeloid LeukaemiaDOI 10.1101/2025.10.03.680259
Select a neighboring publication to make it the new centre.